Ces Urol 2020, 24(2):113-125 | DOI: 10.48095/cccu2020014

Renal tumor biopsy - indications, technique, results

Jiří Kolář1, Tomáš Pitra1, Kristýna Pivovarčíková2, Ivan Trávníček1, František Lepič3, Ondřej Hes2, Milan Hora1
1 Urologická klinika LF UK a FN Plzeň
2 Šiklův ústav patologie LF UK a FN Plzeň
3 Klinika zobrazovacích metod LF UK a FN Plzeň

Kolář J, Pitra T, Pivovarčíková K, Trávníček I, Lepič F, Hes O, Hora M. Renal tumor biopsy - indications, technique, results.

Aim: To evaluate kidney biopsies performed at our department and to compare the data with the literature.

Material and methods: A retrospective analysis of patients who underwent renal tumor biopsy during the years 2007-2019.

Results: During the time period I/2017-XII/2019, we performed renal tumor biopsy on 200 patients at our department - 128 men (64.0 %) and 72 women (36.0 %). The average age of the patients was 64.8 years (34-85 years). Most of the biopsies were performed under CT guidance (n = 192; 96.0 %), a minority of the biopsies performed under ultrasonography guidance (n = 8; 4.0 %). The most common indication for the kidney biopsy was histological verification in metastatic disease before the beginning of oncologic treatment (n = 162; 81.0 %), the histological verification of unclear lesions (n = 32; 16.0 %) and biopsy prior to radiofrequency ablation (n = 6; 3.0 %). The initial biopsies were diagnostic in 165 cases (82.5 %). The most common histological findings were clear cell renal cell carcinoma (n = 107; 53.5 %), papillary renal cell carcinoma (n = 19; 9.5 %), urothelial carcinoma (n = 15; 7.5 %) and chromophobe renal cell carcinoma (n = 3; 1.5 %). The remainder of histological findings were collected from 21 patients (10.5 %). Non-diagnostic were 35 histological samples (17.5 %); re-biopsy was performed in 17 cases from which 16 were positive. In the remaining 18 cases biopsy was not performed again (due to the deterioration of patient's health (n = 6), due to re-biopsy being refused by the patient (n = 2), due to the absence of suspicion for the malignant tumor (n = 4) and finally, 6 of the patients underwent surgery and had the histological examination performed from the removed tissue). The most serious complication was in the form of perirenal hematoma which required blood transfusion (Clavien 2).

Conclusion: At our department, we performed the biopsy of the kidney on 200 patients during 2007-2019, under CT guidance in the vast majority of cases. The most common indication was histological verification preceding oncological treatment and the most common finding was clear renal carcinoma.

Keywords: Biopsy, carcinoma, diagnosis, histology, kidney.………

Received: February 16, 2020; Revised: April 21, 2020; Accepted: May 13, 2020; Prepublished online: May 13, 2020; Published: June 23, 2020 


References

  1. Capitanio U, Bensalah K, Bex A, et al. Epidemiology of Renal Cell Carcinoma. Eur Urol 2019; 75(1): 74-84. Go to original source... Go to PubMed...
  2. Capitanio U, Montorsi F. Renal cancer. Lancet 2016; 387(10021): 894-906. Go to original source... Go to PubMed...
  3. Lane BR, Samplaski MK, Herts BR, et al. Renal mass biopsy - a renaissance? J Urol 2008; 179(1): 20-27. Go to original source... Go to PubMed...
  4. Golan S, Lotan P, Tapiero S, et al. Diagnostic Needle Biopsies in Renal Masses: Patient and Physician Perspectives. Eur Urol Focus 2018; 4(5): 749-753. Go to original source... Go to PubMed...
  5. Leppert JT, Hanley J, Wagner TH, et al. Utilization of renal mass biopsy in patients with renal cell carcinoma. Urology 2014; 83(4): 774-779. Go to original source... Go to PubMed...
  6. Ordon M, Landman J. Renal mass biopsy: "just do it". J Urol 2013; 190(5): 1638-1640. Go to original source... Go to PubMed...
  7. Richard PO, Jewett MA, Bhatt JR, et al. Renal Tumor Biopsy for Small Renal Masses: A Single‑center 13-year Experience. Eur Urol 2015; 68(6): 1007-1013. Go to original source... Go to PubMed...
  8. Ljungberg B, Albiges L, Abu‑Ghanem Y, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update. Eur Urol 2019; 75(5): 799-810. Go to original source... Go to PubMed...
  9. Patel HD, Druskin SC, Rowe SP, et al. Surgical histopathology for suspected oncocytoma on renal mass biopsy: a systematic review and meta‑analysis. BJU Int 2017; 119(5): 661-666. Go to original source... Go to PubMed...
  10. Haifler M, Kutikov A. Update on Renal Mass Biopsy. Curr Urol Rep 2017; 18(4): 28. Go to original source... Go to PubMed...
  11. Delahunt B, Samaratunga H, Martignoni G, et al. Percutaneous renal tumour biopsy. Histopathology 2014; 65(3): 295-308. Go to original source... Go to PubMed...
  12. Volpe A, Finelli A, Gill IS, et al. Rationale for percutaneous biopsy and histologic characterisation of renal tumours. Eur Urol 2012; 62(3): 491-504. Go to original source... Go to PubMed...
  13. Tomaszewski JJ, Uzzo RG, Smaldone MC. Heterogeneity and renal mass biopsy: a review of its role and reliability. Cancer Biol Med 2014; 11(3): 162-172.
  14. Chang DT, Sur H, Lozinskiy M, Wallace DM. Needle tract seeding following percutaneous biopsy of renal cell carcinoma. Korean J Urol 2015; 56(9): 666-669. Go to original source... Go to PubMed...
  15. Soares D, Ahmadi N, Crainic O, Boulas J. Papillary Renal Cell Carcinoma Seeding along a Percutaneous Biopsy Tract. Case Rep Urol 2015; 2015: 925254. Go to original source... Go to PubMed...
  16. Viswanathan A, Ingimarsson JP, Seigne JD, Schned AR. A single‑centre experience with tumour tract seeding associated with needle manipulation of renal cell carcinomas. Can Urol Assoc J 2015; 9(11-12): E890-E893. Go to original source... Go to PubMed...
  17. Laird A, Couper CH, Glancy S, O´Donnell M, Riddick AC. Renal cell carcinoma needle biopsy: sowing the seed for later complications? BMJ Case Rep 2014; 2014. Go to original source... Go to PubMed...
  18. Macklin PS, Sullivan ME, Tapping CR, et al. Tumour Seeding in the Tract of Percutaneous Renal Tumour Biopsy: A Report on Seven Cases from a UK Tertiary Referral Centre. Eur Urol 2019; 75(5): 861-867. Go to original source... Go to PubMed...
  19. Hora M, Philip S, Macklin, et al. Tumour Seeding in the Tract of Percutaneous Renal Tumour Biopsy: A Report on Seven Cases from a UK Tertiary Referral Centre. Eur Urol 2019; 75: 861-867. Eur Urol 2019; 76(4): e96. Go to original source... Go to PubMed...
  20. Procházková K, Mírka H, Trávníček I, et al. Cystic Appearance on Imaging Methods (Bosniak III‑IV) in Histologically Confirmed Papillary Renal Cell Carcinoma is Mainly Characteristic of Papillary Renal Cell Carcinoma Type 1 and Might Predict a Relatively Indolent Behavior of Papillary Renal Cell Carcinoma. Urol Int 2018; 101(4): 409-416. Go to original source... Go to PubMed...
  21. Patel HD, Johnson MH, Pierorazio PM, et al. Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the Literature. J Urol 2016; 195(5): 1340-1347. Go to original source... Go to PubMed...
  22. Marconi L, Dabestani S, Lam TB, et al. Systematic Review and Meta‑analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016; 69(4): 660-673. Go to original source... Go to PubMed...
  23. Kockelbergh R, Griffiths L. Renal Tumour Biopsy - A New Standard of Care? Eur Urol 2016; 69(4): 674-675. Go to original source... Go to PubMed...
  24. Jeon HG, Seo SI, et al. Percutaneous Kidney Biopsy for a Small Renal Mass: A Critical Appraisal of Results. J Urol 2016; 195(3): 568-573. Go to original source... Go to PubMed...
  25. Jason Abel E. Percutaneous biopsy facilitates modern treatment of renal masses. Abdom Radiol (NY). 2016; 41(4): 617-619. Go to original source... Go to PubMed...
  26. Ball MW, Bezerra SM, Gorin MA, et al. Grade heterogeneity in small renal masses: potential implications for renal mass biopsy. J Urol 2015; 193(1): 36-40. Go to original source... Go to PubMed...
  27. Kutikov A, Smaldone MC, Uzzo RG, et al. Renal Mass Biopsy: Always, Sometimes, or Never? Eur Urol 2016; 70(3): 403-406. Go to original source... Go to PubMed...
  28. Rioux‑Leclercq N, Karakiewicz PI, Trinh QD, et al. Prognostic ability of simplified nuclear grading of renal cell carcinoma. Cancer 2007; 109(5): 868-874. Go to original source... Go to PubMed...
  29. Richard PO, Jewett MA, Tanguay S, et al. Safety, reliability and accuracy of small renal tumour biopsies: results from a multi‑institution registry. BJU Int 2017; 119(4): 543-549. Go to original source... Go to PubMed...
  30. Millet I, Curros F, Serre I, Taourel P, Thuret R. Can renal biopsy accurately predict histological subtype and Fuhrman grade of renal cell carcinoma? J Urol 2012; 188(5): 1690-1694. Go to original source... Go to PubMed...
  31. Kouřilová K, Fabišovský M, Dvořáčková J, et al. Výsledky biopsie renálních tumorů na urologickém oddělení FN Ostrava. Ces Urol 2013; 17(3): 199-203.
  32. Leveridge MJ, Finelli A, Kachura JR, et al. Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur Urol 2011; 60(3): 578-584. Go to original source... Go to PubMed...
  33. Volpe A, Mattar K, Finelli A, et al. Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience. J Urol 2008; 180(6): 2333-2337. Go to original source... Go to PubMed...
  34. Veltri A, Garetto I, Tosetti I, et al. Diagnostic accuracy and clinical impact of imaging‑guided needle biopsy of renal masses. Retrospective analysis on 150 cases. Eur Radiol 2011; 21(2): 393-401. Go to original source... Go to PubMed...
  35. Abel EJ, Heckman JE, Hinshaw L, et al. Multi‑Quadrant Biopsy Technique Improves Diagnostic Ability in Large Heterogeneous Renal Masses. J Urol 2015; 194(4): 886-891. Go to original source... Go to PubMed...
  36. Méjean A, Ravaud A, Thezenas S, et al. Sunitinib Alone or after Nephrectomy in Metastatic Renal‑Cell Carcinoma. N Engl J Med 2018; 379(5): 417-427. Go to original source... Go to PubMed...





Web časopisu Česká urologie je určen pouze pro lékaře a odborníky
z oblasti medicíny nebo farmacie.



Beru na vědomí, že informace zveřejněné na těchto stránkách
nejsou určeny pro laickou veřejnost.



Odejít Vstoupit